IMO they will partner with Biotron for covid19 treatment. Biotrons compounds target the e protein that stops replication and also controls the bodies t cell response. Within the next 3 month is my guess.
- Forums
- ASX - By Stock
- CSL
- AstraZeneca May Resume COVID-19 Vaccine Trials Next Week: FT
AstraZeneca May Resume COVID-19 Vaccine Trials Next Week: FT, page-8
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$289.10 |
Change
1.140(0.40%) |
Mkt cap ! $139.7B |
Open | High | Low | Value | Volume |
$288.40 | $289.45 | $287.63 | $178.7M | 622.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 230 | $289.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$289.23 | 328 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7 | 288.980 |
2 | 973 | 288.640 |
1 | 78 | 288.500 |
1 | 973 | 288.460 |
1 | 973 | 288.280 |
Price($) | Vol. | No. |
---|---|---|
289.260 | 500 | 1 |
289.280 | 102 | 2 |
289.390 | 57 | 1 |
289.490 | 20 | 1 |
289.500 | 745 | 6 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
$289.06 |
  |
Change
1.140 ( 0.53 %) |
|||
Open | High | Low | Volume | ||
$288.42 | $289.39 | $287.61 | 103055 | ||
Last updated 15.59pm 14/06/2024 ? |
Featured News
CSL (ASX) Chart |